Liquidia (LQDA) Interest Expenses (2019 - 2026)
Liquidia (LQDA) posted quarterly Interest Expenses of $269.4 million for Q1 2026, up 202.17% year-over-year from $89.1 million in Q1 2025, and up 3804.22% quarter-over-quarter from $6.9 million in Q4 2025.
Liquidia (LQDA) Interest Expenses (2019 - 2026) Analysis & Trends
Liquidia's Interest Expenses history runs 8 years deep, the most recent figure standing at $269.4 million for Q1 2026.
- In Q1 2026, Interest Expenses rose 202.17% year-over-year to $269.4 million; the TTM figure through Mar 2026 stood at $269.4 million (up 202.17% YoY), while the FY2025 annual figure was $248.9 million, up 116.44% from the prior year.
- Interest Expenses for Q1 2026 stood at $269.4 million, up from $6.9 million in the prior quarter.
- The five-year high for Interest Expenses was $269.4 million in Q1 2026, with the low at -$705000.0 in Q4 2022.
- The 5-year median for Interest Expenses is $22.7 million (2023), against an average of $52.5 million.
- The sharpest annual moves came in 2022 and 2023: Interest Expenses plunged 718.42% in 2022, then surged 1573.53% in 2023.
- Liquidia's Interest Expenses stood at -$705000.0 in 2022, then soared by 378.3% to $2.0 million in 2023, then soared by 129.71% to $4.5 million in 2024, then soared by 53.07% to $6.9 million in 2025, then jumped by 3804.22% to $269.4 million in 2026.
- Business Quant data shows LQDA's Interest Expenses at $269.4 million in Q1 2026, $6.9 million in Q4 2025, and $153.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | -400.56 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 2.90 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | 120.70 Mn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 2.90 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 59.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Liquidia | 6.40 Bn | 6.12 Bn | 160.92 Mn | 6.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 583.59 Mn |
| Jun 30, 2026 | 583.59 Mn |
| Mar 31, 2026 | 269.35 Mn |
| Mar 31, 2026 | 269.35 Mn |
| Dec 31, 2025 | 6.90 Mn |
| Dec 31, 2025 | 6.90 Mn |
| Sep 30, 2025 | 153.32 Mn |
| Sep 30, 2025 | 153.32 Mn |
| Jun 30, 2025 | 68.47 Mn |
| Jun 30, 2025 | 68.47 Mn |
| Mar 31, 2025 | 89.14 Mn |
| Mar 31, 2025 | 89.14 Mn |
| Dec 31, 2024 | 4.51 Mn |
| Dec 31, 2024 | 4.51 Mn |
| Sep 30, 2024 | 47.84 Mn |
| Sep 30, 2024 | 47.84 Mn |
| Jun 30, 2024 | 67.98 Mn |
| Jun 30, 2024 | 67.98 Mn |
| Mar 31, 2024 | 95.04 Mn |
| Mar 31, 2024 | 95.04 Mn |